BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19554373)

  • 1. Comprehensive analysis of the clinical significance of inducing pluripotent stemness-related gene expression in colorectal cancer cells.
    Saiki Y; Ishimaru S; Mimori K; Takatsuno Y; Nagahara M; Ishii H; Yamada K; Mori M
    Ann Surg Oncol; 2009 Sep; 16(9):2638-44. PubMed ID: 19554373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.
    Le Magnen C; Bubendorf L; Ruiz C; Zlobec I; Bachmann A; Heberer M; Spagnoli GC; Wyler S; Mengus C
    Eur J Cancer; 2013 Mar; 49(4):955-63. PubMed ID: 23089465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced pluripotent stem cell-related genes influence biological behavior and 5-fluorouracil sensitivity of colorectal cancer cells.
    Shi Z; Bai R; Fu ZX; Zhu YL; Wang RF; Zheng S
    J Zhejiang Univ Sci B; 2012 Jan; 13(1):11-9. PubMed ID: 22205615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A signature for induced pluripotent stem cell-associated genes in colorectal cancer.
    Liu YH; Li Y; Liu XH; Sui HM; Liu YX; Xiao ZQ; Zheng P; Chen L; Yao S; Xing C; Zhou J; Li JM
    Med Oncol; 2013 Mar; 30(1):426. PubMed ID: 23307247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of clinical significance of stem-cell related factors in renal cell cancer.
    Liu Y; Zhang C; Fan J; Xiao L; Yin B; Zhou L; Xia S
    World J Surg Oncol; 2011 Oct; 9():121. PubMed ID: 21982273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells.
    Bae KM; Su Z; Frye C; McClellan S; Allan RW; Andrejewski JT; Kelley V; Jorgensen M; Steindler DA; Vieweg J; Siemann DW
    J Urol; 2010 May; 183(5):2045-53. PubMed ID: 20303530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell fate determination factor Dachshund reprograms breast cancer stem cell function.
    Wu K; Jiao X; Li Z; Katiyar S; Casimiro MC; Yang W; Zhang Q; Willmarth NE; Chepelev I; Crosariol M; Wei Z; Hu J; Zhao K; Pestell RG
    J Biol Chem; 2011 Jan; 286(3):2132-42. PubMed ID: 20937839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced overexpression of Oct4A in human dental pulp cells enhances pluripotency and multilineage differentiation capability.
    Liu L; Wu L; Wei X; Ling J
    Stem Cells Dev; 2015 Apr; 24(8):962-72. PubMed ID: 25422984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines.
    Okada M; Yoneda Y
    Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced efficiency of generating induced pluripotent stem (iPS) cells from human somatic cells by a combination of six transcription factors.
    Liao J; Wu Z; Wang Y; Cheng L; Cui C; Gao Y; Chen T; Rao L; Chen S; Jia N; Dai H; Xin S; Kang J; Pei G; Xiao L
    Cell Res; 2008 May; 18(5):600-3. PubMed ID: 18414447
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic significance of NANOG and KLF4 for breast cancer.
    Nagata T; Shimada Y; Sekine S; Hori R; Matsui K; Okumura T; Sawada S; Fukuoka J; Tsukada K
    Breast Cancer; 2014 Jan; 21(1):96-101. PubMed ID: 22528804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression Nanog activates pluripotent genes in porcine fetal fibroblasts and nuclear transfer embryos.
    Zhang L; Luo YB; Bou G; Kong QR; Huan YJ; Zhu J; Wang JY; Li H; Wang F; Shi YQ; Wei YC; Liu ZH
    Anat Rec (Hoboken); 2011 Nov; 294(11):1809-17. PubMed ID: 21972213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of clinically relevant "induced pluripotent stem" (iPS) cells.
    Heffernan C; Sumer H; Verma PJ
    J Stem Cells; 2011; 6(3):109-27. PubMed ID: 23264997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma.
    Cheng SW; Tsai HW; Lin YJ; Cheng PN; Chang YC; Yen CJ; Huang HP; Chuang YP; Chang TT; Lee CT; Chao A; Chou CY; Chan SH; Chow NH; Ho CL
    PLoS One; 2013; 8(11):e80053. PubMed ID: 24244607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gata4 blocks somatic cell reprogramming by directly repressing Nanog.
    Serrano F; Calatayud CF; Blazquez M; Torres J; Castell JV; Bort R
    Stem Cells; 2013 Jan; 31(1):71-82. PubMed ID: 23132827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.
    Takahashi K; Yamanaka S
    Cell; 2006 Aug; 126(4):663-76. PubMed ID: 16904174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression analysis of iPS cell - inductive genes in esophageal squamous cell carcinoma by tissue microarray.
    Shimada Y; Okumura T; Sekine S; Moriyama M; Sawada S; Matsui K; Yoshioka I; Hojo S; Yoshida T; Nagata T; Fukuoka J; Tsukada K
    Anticancer Res; 2012 Dec; 32(12):5507-14. PubMed ID: 23225459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism.
    Martinez-Fernandez A; Nelson TJ; Yamada S; Reyes S; Alekseev AE; Perez-Terzic C; Ikeda Y; Terzic A
    Circ Res; 2009 Sep; 105(7):648-56. PubMed ID: 19696409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generating induced pluripotent stem cells from common marmoset (Callithrix jacchus) fetal liver cells using defined factors, including Lin28.
    Tomioka I; Maeda T; Shimada H; Kawai K; Okada Y; Igarashi H; Oiwa R; Iwasaki T; Aoki M; Kimura T; Shiozawa S; Shinohara H; Suemizu H; Sasaki E; Okano H
    Genes Cells; 2010 Sep; 15(9):959-69. PubMed ID: 20670273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia and TP53 deficiency for induced pluripotent stem cell-like properties in gastrointestinal cancer.
    Hoshino H; Nagano H; Haraguchi N; Nishikawa S; Tomokuni A; Kano Y; Fukusumi T; Saito T; Ozaki M; Sakai D; Satoh T; Eguchi H; Sekimoto M; Doki Y; Mori M; Ishii H
    Int J Oncol; 2012 May; 40(5):1423-30. PubMed ID: 22293932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.